Uumc Gastroenterology 50 N Medical Dr, Salt Lake City, UT 84132University of Utah Hospitals & Clinics 1525 W 2100 S, Salt Lake City, UT 84119Va Salt Lake City Health Care System 500 Foothill Dr, Salt Lake City, UT 84148
Kathryn Anne Peterson, Salt Lake City UT
Specialties:
Gastroenterologist
Address:
1525 W 2100 S, Salt Lake City, UT 84119 30 N 1900 E, Salt Lake City, UT 84132 50 N Medical Dr, Salt Lake City, UT 84132
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)
Administrative Assistant At S.k. Hart
Position:
Administrative Assistant at S.K. Hart
Location:
Greater Salt Lake City Area
Industry:
Design
Work:
S.K. Hart
since Jan 2011
-
Administrative AssistantKara Chocolates
Aug 2003 - Aug 2010
-
Graphic Designer
Dr. Kathryn A Peterson - MD (Doctor of Medicine)
Hospitals:
University Of Utah Hospital-GAS 50 N Medical Dr SUITE 3, Salt Lake City 84132 University of Utah Health Care 50 North Medical Dr, Salt Lake City 84132 University Of Utah Hospital-GAS 50 N Medical Dr SUITE 3, Salt Lake City 84132 University of Utah Health Care 50 North Medical Dr, Salt Lake City 84132
Education:
Medical Schools University of Texas Southwestern Medical Center At Dallas
Cosmetics Professional
Location:
Greater Salt Lake City Area
Industry:
Cosmetics
Online Content Strategist
Location:
Greater Salt Lake City Area
Industry:
Online Media
Interests:
Religion, politics, literature, the arts, biking, volunteering, health and nutrition
Languages:
Spanish
Mapping In Vivo Eosinophil Activation In Eosinophilic Esophagitis
US Patent:
2013017, Jul 4, 2013
Filed:
Apr 4, 2011
Appl. No.:
13/639770
Inventors:
Kathryn Peterson - Salt Lake City UT, US Gerald J. Gleich - Salt Lake City UT, US
Assignee:
UNIVERSITY OF UTAH RESEARCH FOUNDATION - Salt Lake City UT
International Classification:
A61K 51/10
US Classification:
424 149, 424 91, 424 9341
Abstract:
Provided are compositions and methods for diagnosing eosinophilic esophagitis in a mammalian subject. Further provided are methods of monitoring the course of eosinophilic esophagitis in a subject diagnosed with the disease.